Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled Trial to Determine the Safety and Efficacy of Estetrol (E4) for the Treatment of Patients With Confirmed SARS-COV-2 Infection

NCT04801836 is registered in ClinicalTrials.gov with NEURALIS s.a. as lead sponsor.

NCT NCT04801836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04801836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled Trial to Determine the Safety and Efficacy of Estetrol (E4) for the Treatment of Patients With Confirmed SARS-COV-2 Infection
Lead sponsor
NEURALIS s.a.
Phase
Phase 2
Overall status
Unknown status
Start date
November 19, 2020
Completion date
August 5, 2022
Enrollment
162 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

covid19